SAN DIEGO –– OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced a collaboration with the University of California, Los Angeles (UCLA) and PerkinElmer, Inc. to help researchers develop biomarker tests to evaluate a patient’s immune response to cancer. This research supports the ongoing shift in oncology toward therapeutic strategies that […]
Following its successful acquisition and integration of Cytocell Ltd, Oxford Gene Technology (OGT), the molecular genetics company, has provided an operational and financial update for the company’s financial year ended 30 September 2014. Operational highlights Creation of a focused molecular genetics business addressing large markets in cancer, molecular cytogenetics and reproductive health with a class-leading […]
CANOGA PARK, Calif. — One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of research and in vitro diagnostic products for the HLA transplant community, today launched its RUO NXType™ Kit, a research use only (RUO) solution for human leukocyte antigen (HLA) typing by next-generation sequencing (NGS). The NXType sequencing kits feature long-range […]
Männedorf, Switzerland — The Tecan Group (SIX Swiss Exchange: TECN) today issued a trading update for the second half of 2014. Tecan CEO David Martyr commented: “After a difficult first half with declining sales and our Partnering Business suffering from delays in order placement from two large customer accounts, it is good to see the […]
SUNNYVALE, Calif. — Cepheid (NASDAQ: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® Norovirus, a qualitative in vitro diagnostic test for expeditious identification and differentiation of Noroviruses genogroup I (GI) and genogroup II (GII). Both Xpert Norovirus and the recently cleared Xpert Flu/RSV XC have […]
MIDDLETOWN, Va.– To answer the healthcare industry’s demand for better point-of-care (POC) diagnostics, Thermo Fisher Scientific Inc. and Samsung Electronics Co., Ltd. have formed a strategic collaboration. The companies will jointly design, develop and market new POC solutions in key applications, such as the detection of sepsis, drugs of abuse and therapeutic drug monitoring as […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced it has named two new business presidents and realigned its businesses to better serve customers. Patrick Kaltenbach has been named senior vice president, Agilent, and president of the Life Sciences and Applied Markets Group (LSAG) business unit, which combines the former Chemical Analysis Group […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it is collaborating with the Tuberous Sclerosis Alliance (TS Alliance) by sharing its data on genetic variants in an international database for the […]
PSS Board Director, Kimimitchi Obata (Global Sales & Marketing Division, Executive Officer) has passed away because of gastric cancer to Sunday, November 16, 2014. Along with this, he has resigned as a director with the same date. We thank Dr Obata and his family for close association during his lifetime, and provide our heartfelt appreciation. […]
Sydney, Australia –- Genetic Signatures Ltd has launched its prospectus offering institutional and retail investors the opportunity to invest in the exciting growing global molecular diagnostics market prior to the Company’s listing on the Australian Stock Exchange on 23 December 2014. Molecular diagnostics (MDx) is a modern technique increasingly used by hospitals and pathology labs […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
